MMV is seeking to fill the following posts to join our dedicated team:

Deadline: 21 August 2015

Image of the week

The Wellcome Trust features MMV’s Malaria Box as the image of the week.

Development Policy Blog

MMV's CEO, David Reddy, speaks about partnerships and innovation to defeat malaria.

Latest science article

A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria


Technical brief presents recommendations for the control and elimination of P. vivax malaria

29 July 2015

PATH report selects OZ439 for its promise as a synthetic antimalarial drug candidate

16 July 2015

DSM265 shows potential to cure and protect in a single dose

16 July 2015

Nominated by UK DFID, MMV chosen from a shortlist of 17 open data pioneers

10 July 2015

Discovery of a novel antimalarial compound published in Nature

17 June 2015

Discussions are underway to further strengthen collaboration

05 June 2015